Navigation Links
Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
Date:5/1/2013

platform for the development of active pharmaceutical ingredient(s) (API) and drug products targeting Melioidosis.
  • Soligenix will leverage Intrexon's proprietary platforms and technologies, including the UltraVector® and mAbLogix platforms, LEAP instrument, protein engineering, inducible gene systems, genome engineering, and cell systems engineering to the collaboration's programs.
  • Soligenix will issue to Intrexon 1,034,483 shares of its common stock, representing 8.5% of Soligenix's issued and outstanding shares.
  • Intrexon will be granted the right to participate in securities offerings that may be conducted by Soligenix in the future as well as the right to make purchases of Soligenix's common stock in the open market.
  • Soligenix will pay development milestones and royalties on net sales derived from the sale of products developed from the channel collaboration.
  • For more information regarding the agreement visit http://www.soligenix.com/invest_secfilings.shtml.
  • Griffin Securities served as financial advisor to Intrexon in connection with this transaction.

    About Melioidosis

    Melioidosis is a potentially fatal infection caused by the Gram-negative bacillus, Burkholderia pseudomallei (Bp). Highly resistant to many antibiotics, Bp can cause an acute disease characterized by a fulminant pneumonia and a chronic condition that can recrudesce. There is no preventive vaccine or effective immunotherapy for melioidosis. Therefore, there is a significant medical need for improved prevention and therapy.

    Bp infection (melioidosis) is a major public health concern in the endemic regions of Southeast Asia and Northern Australia. Moreover, the organism has a worldwide distribution and the full extent of global spre
    '/>"/>

    SOURCE Soligenix, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Soligenix to Present at World Vaccine Congress & Expo
    2. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
    3. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
    4. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
    5. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
    6. Soligenix Reports Third Quarter 2012 Financial Results and Highlights Recent Accomplishments
    7. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
    8. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    9. Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
    10. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
    11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... Ariz. , July 1, 2015 Prismic ... drugs and FDA-regulated medical foods, today announced the election ... A. Simonetti to its Board of Directors. ... Board members, Peter Moriarty , Chairman and CEO ... Krivulka and Martin Simonetti have accepted ...
    (Date:7/1/2015)... , July 1, 2015  Imprimis Pharmaceuticals, ... focused on the development and commercialization of proprietary ... will ring The Nasdaq stock market closing bell ... the growing success of its Go Dropless™ campaign ... million cataract procedures are performed annually in the ...
    (Date:7/1/2015)... GAITHERSBURG, Md. , July 1, 2015 ... live biotherapeutics and probiotic treatments, announced today that it ... Canada Natural and Non-prescription Health Products Directorate (NNHPD) to ... Visbiome was developed by Professor Claudio ... subject of extensive clinical investigation. Professor De Simone recently ...
    Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3
    ... , , , INDIANAPOLIS, Dec. 9 ... leading provider of managed voice, Internet and data networking solutions ... that Indiana Blood Center has selected the company to provide ... 11 locations located throughout Indiana. Indiana Blood Center will also ...
    ... , , ... HBP; OTCQX: HXBPF) reports that at its Annual General Meeting ... Board of Directors , All seven Board members were ... of: , ,Donald H. Segal, Chairman of the Board and ...
    Cached Medicine Technology:Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3
    (Date:7/1/2015)... ... ... Camp wasn’t always a steadfast supporter of plastic surgery. But just as her career ... a terrible car accident years ago left her injured and in need of reconstructive ... What if I Do?): Answers to All Your Questions about Plastic Surgery” (published by Archway ...
    (Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... Who ... meaning and purpose in life with a healthy balance between work and life, and ... this in her new book, Positive Health: Flourishing Lives, Wellbeing in Doctors. , With ...
    (Date:7/1/2015)... McLean, Va. (PRWEB) , ... July 01, 2015 , ... ... PRF in partnership with PAPRS, welcomed Scott Stossel, editor of The Atlantic, as a ... his personal experience combatting anxiety, and how telling his personal story added power and ...
    (Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers ... tested to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor ... quality Thule owners have come to expect. , The Thule Atmos X4 ...
    (Date:7/1/2015)... Wis. (PRWEB) , ... July 01, 2015 , ... ... identification (RFID) safety and security solutions, has partnered with WIU Crossroads School in ... Duress Solution. The unique AEDY (Alternative Education for Disruptive Youth) environment of Crossroads ...
    Breaking Medicine News(10 mins):Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3
    ... Activity level drops among women at certain times of year, ... changes can interfere with people,s attempts to get regular exercise, ... more in the summer and less in the winter. ... levels were monitored for 18 months. Based on pedometer readings, ...
    ... grant to impact underserved communities around the world , ... ... uncertain economy, Illinois College of Optometry (ICO) students are ... humanitarian missions through Student Volunteers in Optometric Service to Humanity (SVOSH). ...
    ... 13 /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS) ... a health care UK based company that has developed ... European countries, and already has the FDA approval (or ... food grade ingredients that are FDA approved. , HTDS ...
    ... Feb. 13 American Network, Inc., announced today that ... services for the Deaf and Hard of Hearing communities. ... and a great success as it forays into TRS ... Deaf and Hard of Hearing.PhoneCaption,s service uses innovative, patent-pending ...
    ... have been indicted in connection with an alleged $10 ... a Miami clinic that purported to specialize in treating ... of the Criminal Division and U.S. Attorney R. Alexander ... del Cueto, M.D., 65, Roberto Rodriguez, M.D., 54, Carlos ...
    ... With Threats of Closures, LayoffsLOUISVILLE, Ky., Feb. 13 ... than 3,000 health care workers at nine Appalachian ... and southern West Virginia today called on the ... to discuss recent cost-cutting proposals that will adversely ...
    Cached Medicine News:Health News:Winter's Cold, Summer's Heat Take a Toll 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 3Health News:Cash-strapped Optometry Students Give Back in a Big Way 4Health News:Hard To Treat Diseases (HTDS) Negotiating to Merge with a UK Health Care Company 2Health News:PhoneCaption Provides Free Captioning Services for Deaf and Hard of Hearing 2Health News:Three Miami Physicians and Three Medical Workers Charged With $10 Million Medicare Fraud Scheme 2Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 2Health News:Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals' Bottom Line 3
    ... Simplex™ P with Tobramycin ... Bone Cement formula, with the ... By maintaining the original formula, ... performance characteristics of Simplex™ P ...
    ... Flow Analyzer is a fast, clinically proven ... of low and normal-tension glaucoma., ,The Ocular ... clinically proven measurement that improves detection of ... management of glaucoma, and detection of other ...
    ... Flexible Dosposable Easy Insertion/Removal ... (CSS) provides absolutely reliable support to ... thereby permitting routine phacoemulsification regardless of ... easy (similar to disposable iris retractors), ...
    The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
    Medicine Products: